SARTORIUS AG (SRT.DE) Stock Fundamental Analysis
FRA:SRT - Deutsche Boerse Ag - DE0007165607 - Common Stock - Currency: EUR
Taking everything into account, SRT scores 3 out of 10 in our fundamental rating. SRT was compared to 15 industry peers in the Life Sciences Tools & Services industry. SRT may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, SRT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year SRT was profitable.
SRT had a positive operating cash flow in the past year.
SRT had positive earnings in each of the past 5 years.
SRT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of SRT (0.83%) is worse than 66.67% of its industry peers.
The Return On Equity of SRT (3.03%) is worse than 60.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.37%, SRT is doing worse than 73.33% of the companies in the same industry.
SRT had an Average Return On Invested Capital over the past 3 years of 8.34%. This is in line with the industry average of 6.90%.
The 3 year average ROIC (8.34%) for SRT is well above the current ROIC(3.37%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.83% | ||
| ROE | 3.03% | ||
| ROIC | 3.37% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
The Profit Margin of SRT (2.48%) is worse than 66.67% of its industry peers.
SRT's Profit Margin has declined in the last couple of years.
SRT has a Operating Margin of 11.60%. This is in the lower half of the industry: SRT underperforms 60.00% of its industry peers.
In the last couple of years the Operating Margin of SRT has declined.
Looking at the Gross Margin, with a value of 45.09%, SRT is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
SRT's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.6% | ||
| PM (TTM) | 2.48% | ||
| GM | 45.09% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SRT is creating some value.
The number of shares outstanding for SRT has been increased compared to 1 year ago.
SRT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SRT has been reduced compared to a year ago.
2.2 Solvency
SRT has an Altman-Z score of 1.93. This is not the best score and indicates that SRT is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.93, SRT is doing worse than 73.33% of the companies in the same industry.
The Debt to FCF ratio of SRT is 8.05, which is on the high side as it means it would take SRT, 8.05 years of fcf income to pay off all of its debts.
SRT has a Debt to FCF ratio of 8.05. This is in the lower half of the industry: SRT underperforms 66.67% of its industry peers.
SRT has a Debt/Equity ratio of 1.51. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.51, SRT is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.51 | ||
| Debt/FCF | 8.05 | ||
| Altman-Z | 1.93 |
ROIC/WACC0.48
WACC7.01%
2.3 Liquidity
A Current Ratio of 1.46 indicates that SRT should not have too much problems paying its short term obligations.
SRT has a Current ratio (1.46) which is in line with its industry peers.
SRT has a Quick Ratio of 1.46. This is a bad value and indicates that SRT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.92, SRT is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.46 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
SRT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.38%.
Measured over the past years, SRT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.05% on average per year.
The Revenue for SRT has decreased by -18.66% in the past year. This is quite bad
The Revenue has been growing by 16.74% on average over the past years. This is quite good.
EPS 1Y (TTM)-48.38%
EPS 3Y4.09%
EPS 5Y14.05%
EPS Q2Q%N/A
Revenue 1Y (TTM)-18.66%
Revenue growth 3Y13.29%
Revenue growth 5Y16.74%
Sales Q2Q%7.74%
3.2 Future
Based on estimates for the next years, SRT will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.08% on average per year.
The Revenue is expected to grow by 6.85% on average over the next years.
EPS Next Y-17.05%
EPS Next 2Y0.97%
EPS Next 3Y8.7%
EPS Next 5Y12.08%
Revenue Next Year-1.28%
Revenue Next 2Y3.1%
Revenue Next 3Y5.47%
Revenue Next 5Y6.85%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 42.72 indicates a quite expensive valuation of SRT.
60.00% of the companies in the same industry are cheaper than SRT, based on the Price/Earnings ratio.
SRT is valuated expensively when we compare the Price/Earnings ratio to 28.33, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 36.22, the valuation of SRT can be described as expensive.
Based on the Price/Forward Earnings ratio, SRT is valued a bit more expensive than 73.33% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.37, SRT is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.72 | ||
| Fwd PE | 36.22 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SRT is valued a bit more expensive than 60.00% of the companies in the same industry.
SRT's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.12 | ||
| EV/EBITDA | 20.59 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)3.04
EPS Next 2Y0.97%
EPS Next 3Y8.7%
5. Dividend
5.1 Amount
With a yearly dividend of 0.42%, SRT is not a good candidate for dividend investing.
SRT's Dividend Yield is comparable with the industry average which is at 0.92.
With a Dividend Yield of 0.42, SRT pays less dividend than the S&P500 average, which is at 2.51.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.42% |
5.2 History
The dividend of SRT has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
SRT pays out 60.57% of its income as dividend. This is not a sustainable payout ratio.
The dividend of SRT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP60.57%
EPS Next 2Y0.97%
EPS Next 3Y8.7%
FRA:SRT (4/22/2025, 5:29:56 PM)
182.4
+9.8 (+5.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners2.79%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.66B
Analysts77.14
Price Target293.76 (61.05%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.42% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP60.57%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.23%
Min EPS beat(2)-22.4%
Max EPS beat(2)-4.06%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-4.07%
Max Revenue beat(2)4.87%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.14%
PT rev (3m)-0.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-1.82%
EPS NY rev (3m)-5.36%
Revenue NQ rev (1m)2.1%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.72 | ||
| Fwd PE | 36.22 | ||
| P/S | 4.04 | ||
| P/FCF | 24.12 | ||
| P/OCF | 13.99 | ||
| P/B | 4.94 | ||
| P/tB | N/A | ||
| EV/EBITDA | 20.59 |
EPS(TTM)4.27
EY2.34%
EPS(NY)5.04
Fwd EY2.76%
FCF(TTM)7.56
FCFY4.15%
OCF(TTM)13.04
OCFY7.15%
SpS45.15
BVpS36.92
TBVpS-36.12
PEG (NY)N/A
PEG (5Y)3.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.83% | ||
| ROE | 3.03% | ||
| ROCE | 4.53% | ||
| ROIC | 3.37% | ||
| ROICexc | 3.72% | ||
| ROICexgc | 12.35% | ||
| OM | 11.6% | ||
| PM (TTM) | 2.48% | ||
| GM | 45.09% | ||
| FCFM | 16.75% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexcg growth 3Y-35.26%
ROICexcg growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score4
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.51 | ||
| Debt/FCF | 8.05 | ||
| Debt/EBITDA | 5.16 | ||
| Cap/Depr | 98.56% | ||
| Cap/Sales | 12.12% | ||
| Interest Coverage | 1.86 | ||
| Cash Conversion | 120.82% | ||
| Profit Quality | 676.58% | ||
| Current Ratio | 1.46 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.93 |
F-Score4
WACC7.01%
ROIC/WACC0.48
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)-48.38%
EPS 3Y4.09%
EPS 5Y14.05%
EPS Q2Q%N/A
EPS Next Y-17.05%
EPS Next 2Y0.97%
EPS Next 3Y8.7%
EPS Next 5Y12.08%
Revenue 1Y (TTM)-18.66%
Revenue growth 3Y13.29%
Revenue growth 5Y16.74%
Sales Q2Q%7.74%
Revenue Next Year-1.28%
Revenue Next 2Y3.1%
Revenue Next 3Y5.47%
Revenue Next 5Y6.85%
EBIT growth 1Y-22.19%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year101.03%
EBIT Next 3Y38.88%
EBIT Next 5Y26.44%
FCF growth 1Y92.68%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y14.36%
OCF growth 3Y4.07%
OCF growth 5Y20.79%